Ritlecitinib
Indication
Severe alopecia areata in people 12 years and over (NICE TA958)
NICE TA958 - Ritlecitinib for treating severe alopecia areata in people 12 years and over
Red
Brand:
Nice TA:
958
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Skin
Background
1.1 Ritlecitinib is recommended, within its marketing authorisation, as an option for treating severe alopecia areata in people 12 years and over. Ritlecitinib is only recommended if the company provides it according to the commercial arrangement.